| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | 0.14 | 5e-05 |
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0001 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.0001 |
| mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | 0.21 | 0.0002 |
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0003 |
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0004 |
| mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0006 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0008 |